{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:16:59Z","timestamp":1783487819891,"version":"3.55.0"},"reference-count":32,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0395","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T22:06:36Z","timestamp":1603404396000},"page":"299-306","source":"Crossref","is-referenced-by-count":10,"title":["Computed tomography combined with confirmatory tests for the diagnosis of aldosterone-producing adenoma"],"prefix":"10.1507","volume":"68","author":[{"given":"Shihan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panyu","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, et al. (2017) Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol 69: 1811\u20131820.","DOI":"10.1016\/j.jacc.2017.01.052"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Sang X, Jiang Y, Wang W, Li Y, Zhao J, et al. (2013) Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. J Hypertens 31: 1465\u20131471; discussion 1471\u20131472.","DOI":"10.1097\/HJH.0b013e328360ddf6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, et al. (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5: 689\u2013699.","DOI":"10.1016\/S2213-8587(17)30135-3"},{"key":"4","unstructured":"4 Satoh F, Morimoto R, Ono Y, Iwakura Y, Omata K (2015) Clinical benefits of administering super-selective segmental adrenal venous sampling and performing adrenal sparing surgery in the patients with primary aldosteronism. J Hypertens 33 Suppl 1: e114."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Kline GA, Dias VC, So B, Harvey A, Pasieka JL (2014) Despite limited specificity, computed tomography predicts lateralization and clinical outcome in primary aldosteronism. World J Surg 38: 2855\u20132862.","DOI":"10.1007\/s00268-014-2694-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kline GA, So B, Dias VC, Harvey A, Pasieka JL (2013) Catheterization during adrenal vein sampling for primary aldosteronism: failure to use (1-24) ACTH may increase apparent failure rate. J Clin Hypertens (Greenwich) 15: 480\u2013484.","DOI":"10.1111\/jch.12096"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7 Lethielleux G, Amar L, Raynaud A, Plouin PF, Steichen O (2015) Influence of diagnostic criteria on the interpretation of adrenal vein sampling. Hypertension 65: 849\u2013854.","DOI":"10.1161\/HYPERTENSIONAHA.114.04812"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Auchus RJ, Wians FH Jr, Anderson ME, Dolmatch BL, Trimmer CK, et al. (2010) What we still do not know about adrenal vein sampling for primary aldosteronism. Horm Metab Res 42: 411\u2013415.","DOI":"10.1055\/s-0030-1252060"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, et al. (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101: 1889\u20131916.","DOI":"10.1210\/jc.2015-4061"},{"key":"10","unstructured":"10 Li Y, Liu Y, Li J, Wang X, Yu Y (2016) Sodium infusion test for diagnosis of primary aldosteronism in Chinese population. J Clin Endocrinol Metab 101: 88\u201394."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Meng X, Li Y, Wang X, Li J, Liu Y, et al. (2018) Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary aldosteronism. J Clin Endocrinol Metab 103: 853\u2013860.","DOI":"10.1210\/jc.2017-01530"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12 Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, et al. (2007) Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50: 424\u2013431.","DOI":"10.1161\/HYPERTENSIONAHA.107.091827"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Xiao L, Jiang Y, Zhang C, Jiang L, Zhou W, et al. (2019) A novel clinical nomogram to predict bilateral hyperaldosteronism in Chinese patients with primary aldosteronism. Clin Endocrinol (Oxf) 90: 781\u2013788.","DOI":"10.1111\/cen.13962"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14 Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, et al. (2014) An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 63: 151\u2013160.","DOI":"10.1161\/HYPERTENSIONAHA.113.02097"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, et al. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045\u20131050.","DOI":"10.1210\/jc.2003-031337"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, et al. (2013) Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocr Metab 98: 4826\u20134833.","DOI":"10.1210\/jc.2013-2805"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Salcuni AS, Carnevale V, Battista C, Palmieri S, Eller-Vainicher C, et al. (2017) Primary aldosteronism as a cause of secondary osteoporosis. Eur J Endocrinol 177: 431\u2013437.","DOI":"10.1530\/EJE-17-0417"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Tsurutani Y, SugisawaC, Ishida A, Inoue K, Saito J, et al. (2017) Aldosterone excess may inhibit insulin secretion: a comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism. Endocr J 64: 339\u2013346.","DOI":"10.1507\/endocrj.EJ16-0500"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, et al. (2019) Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism. Eur J Endocrinol 181: 339\u2013350.","DOI":"10.1530\/EJE-19-0047"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Velema M, Dekkers T, Hermus A, Timmers H, Lenders J, et al. (2018) Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment. J Clin Endocrinol Metab 103: 16\u201324.","DOI":"10.1210\/jc.2017-01442"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, et al. (2019) Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism. J Hypertens 37: 1513\u20131520.","DOI":"10.1097\/HJH.0000000000002070"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kater CE, Biglieri EG (2004) The syndromes of low-renin hypertension: \u201cseparating the wheat from the chaff\u201d. Arq Bras Endocrinol Metabol 48: 674\u2013681.","DOI":"10.1590\/S0004-27302004000500013"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Lim PO, Struthers AD, MacDonald TM (2002) The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? J Hypertens 20: 11\u201315.","DOI":"10.1097\/00004872-200201000-00003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, et al. (2013) Regression of left ventricular hypertrophy in patients with primary aldosteronism\/low-renin hypertension on low-dose spironolactone. Nephrol Dial Transplant 28: 1787\u20131793.","DOI":"10.1093\/ndt\/gfs587"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Markou A, Sertedaki A, Kaltsas G, Androulakis, II, Marakaki C, et al. (2015) Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension. J Clin Endocrinol Metab 100: 2857\u20132864.","DOI":"10.1210\/jc.2015-1268"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, et al. (2018) Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism. J Clin Endocrinol Metab 103: 900\u2013908.","DOI":"10.1210\/jc.2017-01774"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Mulatero P, Bertello C, Rossato D, Mengozzi G, Milan A, et al. (2008) Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab 93: 1366\u20131371.","DOI":"10.1210\/jc.2007-2055"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Kempers MJ, Lenders JW, van Outheusden L, van der Wilt GJ, Schultze Kool LJ, et al. (2009) Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med 151: 329\u2013337.","DOI":"10.7326\/0003-4819-151-5-200909010-00007"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Hashimura H, Shen J, Fuller PJ, Chee NYN, Doery JCG, et al. (2018) Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism. Clin Endocrinol (Oxf) 89: 308\u2013313.","DOI":"10.1111\/cen.13757"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Wada N, Miyoshi A, Usubuchi H, Terae S, Shibayama Y, et al. (2020) Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism. Endocr J. Online ahead of print.","DOI":"10.1507\/endocrj.EJ20-0329"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Puar TH, Loh WJ, Lim DS, Loh LM, Zhang M, et al. (2020) Aldosterone-potassium ratio predicts primary aldosteronism subtype. J Hypertens 38: 1375\u20131383.","DOI":"10.1097\/HJH.0000000000002348"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Heinrich DA, Adolf C, Quinkler M, Holler F, Lechner B, et al. (2019) Safety of medical adjustment and confirmatory testing in the diagnostic workup of primary aldosteronism. Eur J Endocrinol 181: 421\u2013428.","DOI":"10.1530\/EJE-19-0138"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/3\/68_EJ20-0395\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T03:26:39Z","timestamp":1617420399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/3\/68_EJ20-0395\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0395","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}